Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Visit https://bibliotekanauki.pl
Title variants
Structure of Health Care Spendings in the European Countries of OECD in the Years 2005–2014
Languages of publication
Abstracts
Celem artykułu jest porównanie struktury wydatków na opiekę zdrowotną w wybranych krajach europejskich należących do OECD w latach 2005–2014, ze szczególnym uwzględnieniem różnic w modelach finansowania ochrony zdrowia. W analizie wykorzystano wskaźniki struktury wydatków bieżących. Finansowanie i organizacja opieki zdrowotnej w europejskich krajach OECD jest bardzo podobna, tzn. fundusze publiczne pochodzą z podatków lub składek na opiekę zdrowotną. Struktura wydatków na opiekę zdrowotną nie jest bardzo zróżnicowana między krajami w zakresie wydatków na leczenie szpitalne i ambulatoryjne. Średnio w analizowanych krajach wydatki te stanowią po około 30% łącznych wydatków bieżących. Wśród analizowanych krajów istnieją duże różnice między wielkością i zakresem wydatków na refundację leków, wydatkami na opiekę długoterminową i wydatkami na administrację systemów ochrony zdrowia.
The aim of the chapter is to compare the structure of various health care spendings in selected European countries belonging to the OECD in the period 2005–2014, with particular emphasis on the differences in models of health care financing. In analysis indicators of current expenditure structure are used. Financing and organization of health care in European OECD countries is very similar i.e. public funds come from taxes or health care contributions. The structure of health care spending is not very varied between countries in terms of inpatient and outpatient care expenditures. On average, in the analyzed countries these spending account for approximately 30% of total current expenditures. Among countries analyzed, there are big differences between the size and scope of the expenses for reimbursement of medicines, long-term care spending, and spending on the administration of health care systems.
Year
Volume
Pages
23-35
Physical description
Contributors
author
- Politechnika Gdańska
References
- Anell A., Willis M., International comparison of health care systems using resource profiles, „Bulletin of the World Health Organization” 2000, vol. 78, no. 6, s. 770–778.
- Belloni A., Morgan D., Paris V., Pharmaceutical Expenditure and Policies: Past Trends and Future Challenges, „OECD Health Working Papers” 2016, no. 87, s. 34; http://dx.doi.org/10.1787/5jm0q1f4cdq7-en.
- Busse R., Blümel M., Germany: health system review. Health Systems in Transition, „European Observatory on Health Systems and Policies” 2014, vol. 16, no. 2, s. 119–120.
- Chawla M., Health care spending in the new EU member states: control-ling costs and improving quality, „World Bank Working Paper” 2007, no. 113, s. 8–20; http://dx.doi.org/10.1596/978-0-8213-7151-0.
- Finansowanie ochrony zdrowia, red. J. Suchecka, ABC a Wolters Kluwer business, Warszawa 2015, s. 28–38.
- Fincham J., Health Policy and Ethics, Pharmaceutical Press, London 2011, s. 24.
- González E., Cárcaba A., Ventura J., Value efficiency analysis of health systems: does public financing play a role?, „Journal of Public Health” 2010, vol. 18, issue 4, s. 337–350; http://dx.doi.org/10.1007/s10389-009-0311-4.
- Implementing Health Financing Reform, Lessons from countries in tran-sition, ed. J., Kutzin, Ch. Cashin, M. Jakab, European Observatory on Health Systems and Policies, 2010, s. 33.
- Jakubowski E., Busse R., Health care systems in the EU. A comparative study, Working Paper, SACO 101 EN. Luxemburg: European Parliament, Directorate General for Research, 1998, s. 17–18.
- Kutzin J., Ibraimova A., Jakab M., O’Dougherty S., Bismarck meets Beve-ridge on the Silk Road: coordinating funding sources to create a univer-sal health financing system in Kyrgyzstan, „Bulletin of the World Health Organization” 2009, vol. 87, no. 7, s. 549–554; http://dx.doi.org/ 10.2471/BLT.07.049544.
- Leopold Ch. Mantel-Teeuwisse A.K., Vogler S., Valkova S., de Joncheere K., Leufkens H.G.M., Wagner A.K., Ross-Degnan D., Laing R., Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries, „Bulletin of the World Health Organization” 2014, vol. 92, no. 9, s. 630–640D; http://dx.doi.org/10.2471/BLT.13.129114.
- Morgan, D., Astolfi R., Health Spending Continues to Stagnate in Many OECD Countries, „OECD Health Working Papers” 2014, no. 68, s. 5–15; http://dx.doi.org/10.1787/5jz5sq5qnwf5-en.
- Mossialos E., Thomson S., Voluntary heath insurance in European Union, WHO 2004, s. 52.
- OECD database, www.stats.oecd.org [dostęp: 10.12.2016].
- OECD/EU, Health at a Glance: Europe 2016 – State of Health in the EU Cycle, OECD Publishing, Paris, 2016, s. 113–123; http://dx.doi.org/ 10.1787/9789264265592-en.
- OECD, Eurostat, WHO, A System of Health Accounts 201: Revised edi-tion, OECD Publishing, Paris, 2017, s. 71–120; http://dx.doi.org/ 10.1787/9789264270985-en.
- Vogler S., Habl C., Leopold C., Rosian-Schikuta I., de Joncheere K., Lyager T.T., PPRI Report, Pharmaceutical Pricing and Reimbursement Information, ÖBIG, Vienna, 2008, s 126.
- Vogler S., Zimmermann N., Leopold C., Joncheere K.D., Pharmaceutical policies in European countries in response to the global financial crisis, „Southern Medical Review” 2011, vol. 4; issue 2, s. 69–79; http://dx.doi.org/10.5655/smr.v4i2.1004.
- Xu K., Evans D.B., Carrin G., Aguilar-Rivera A.M., Designing health fi-nancing systems to reduce catastrophic health expenditure, Technical brief for policy-makers, WHO, 2005, no. 2, s. 1.
Document Type
Publication order reference
Identifiers
ISSN
2300-2999
YADDA identifier
bwmeta1.element.desklight-7e98a0bc-56d3-4d20-9fe8-7a55ac1eb824
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.